ScripsAmerica Provides Corporate Update Highlighting Recent Monthly Revenue Growth

TYSONS CORNER, Va., Oct. 5, 2015 (GLOBE NEWSWIRE) -- Management of ScripsAmerica, Inc. (OTCBB:SCRC) today provided a corporate update including monthly revenue figures for the months of August and September 2015.

Brian Ettinger, the Company's Interim CEO stated:

"Management of ScripsAmerica would like to update its shareholders and the investment community regarding the Company's operations during the third quarter.

Specialty Pharmacy Revenue

ScripsAmerica's specialty pharmacy operations recorded approved orders of $1,136,000 during the month of August and $1,680,000 during September of 2015. This represents 48% month over month growth in revenue from our specialty pharmacy to close the third quarter.

This recent growth is a strong testament to the business development efforts of our President Adam Brosius and the strength of his team which has been working diligently to grow our specialty pharmacy operations by increasing the size of their distribution network throughout the US.

As a result of these efforts, ScripsAmerica has formed multiple new marketing relationships in the specialty pharmacy industry that have already begun and we believe will continue contributing to the growth of our monthly approved orders and revenue."

Interim President Adam Brosius added, 'I am pleased to report that the new nationwide marketing relationships we've brought to ScripsAmerica during the last three months have proven to buck the downward trend that the specialty pharmacy industry is experiencing as a whole right now. While many competing pharmacies in this market are cutting staff and services, Scrips' operations have recently begun increasing both our overall value prescription volume and workforce.'

2014 and 2015 Financial Statements

"Regarding the filing of ScripsAmerica's outstanding financial statements, we would like to inform our shareholders that our management team is working closely with our external auditors to complete the audit of the Company's 2014 financials.

During the third quarter, ScripsAmerica maintained its shares outstanding at 139 million as new management looks to prevent potential stock dilution and enable revenue growth to propel increases in shareholder value as much as possible moving forward," concluded Mr. Ettinger.

About ScripsAmerica, Inc.

ScripsAmerica Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit

Safe Harbor Statement

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT: Seal Point Consulting, LLC 888-959-7095

Source:ScripsAmerica, Inc.